Merit Medical Systems Inc (MMSI) Financials
Key financial figures for Merit Medical Systems Inc (Q3 2026).
Merit Medical Q3 revenue rose 8.4% to $416.2M, non-GAAP EPS was $1.12, and full-year revenue and non-GAAP EPS guidance moved up. Reported revenue was $416.2M, up 8.4% (constant currency up 8%, organic constant currency up 9% excluding the DualCap divestiture); vs FMP estimate of $410.6M. Non-GAAP EPS was $1.12, up 22% from $0.92, vs FMP estimate of $1.04; GAAP diluted EPS was $0.70, up from $0.46. GAAP operating margin was 14.1% (11.1% a year ago) and non-GAAP operating margin 21.3% (19.7%); non-GAAP gross margin slipped to 52.8% from 53.6%. Therapeutic revenue grew 14% to $140.5M (Endoscopy +33%, Oncology +16%), Foundational grew 6% to $275.7M with Procedural Solutions down 16%. On the outlook: Full-year 2026 guidance raised: total revenue $1.635 to $1.642 billion (prior $1.631 to $1.643 billion), up about 8%; non-GAAP EPS $4.33 to $4.37 (prior $4.25 to $4.35), up 13% to 14%. Figures are for Q3 2026, as Merit Medical Systems, Inc. reported them.
- Revenue
- $416M
- Net Income
- $42M
- EPS
- $0.71
- Total Assets
- $2.9B
- Operating Cash Flow
- $65M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $416M | $42M | $0.70 | 14.12% | $52M |
| Q2 FY2026 | $419M | $39M | $0.65 | 14.46% | $51M |
| Q1 FY2026 | $382M | $41M | $0.68 | 11.52% | $24M |
| Q4 FY2025 | $394M | $38M | $0.63 | 13.72% | $77M |
| Q3 FY2025 | $384M | $28M | $0.46 | 11.13% | $52M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $1.5B | $128M | $2.13 | 12.17% | $213M |
| FY2024 | $1.4B | $120M | $2.03 | 11.48% | $183M |
| FY2023 | $1.3B | $94M | $1.62 | 9.86% | $108M |
Frequently asked questions
What was Merit Medical Systems, Inc.'s revenue last quarter?
Merit Medical Systems, Inc. reported revenue of $416.2 million for Q3 FY2026, up 8.3% from the same period a year earlier.
Is Merit Medical Systems, Inc. profitable?
Yes. Merit Medical Systems, Inc. reported net income of $42.3 million for Q3 FY2026, a net margin of 10.16% on revenue.
How has Merit Medical Systems, Inc.'s margin trended?
Operating margin was 14.12% in Q3 FY2026, compared with 11.13% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Merit Medical Systems, Inc. generate?
Merit Medical Systems, Inc. generated free cash flow of $52.3 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Merit Medical Systems Inc on SentiSense, with up to forty quarters and twenty fiscal years of history.